Inpeco and Tosoh Bioscience – Diagnostics EMEA Join Forces to Advance Diagnostic Connectivity
Tosoh’s new HbA1c Analyzer, the HLC-723™GR01, is now connectable to Inpeco’s latest-generation FlexLab™ X Total Laboratory Automation system
Novazzano, Switzerland, 05.11.2025 – Inpeco, the global market leader in Total Laboratory Automation (TLA), is pleased to announce the integration of the new Tosoh HLC-723GR01 HbA1c Analyzer into its FlexLab™ X connectivity portfolio. With this new connection, laboratories can now access Tosoh’s compact and high-performance HbA1c solution within fully automated workflows, combining advanced clinical performance with the efficiency, safety, and scalability of automation.
Built on Proven FlexLab Technology FlexLab™ X is a uniquely open automation system that allows laboratories to freely combine analyzers from over 40 analyzers from 20 leading IVD manufacturers, delivering premium-quality results across 12 clinical specialties. Its flexible and scalable design, based on standardized components, facilitates space-saving layouts and simplifies future upgrades, ensuring the system evolves with laboratory needs.
The Tosoh GR01 delivers precise and reproducible HbA1c results using ion-exchange HPLC technology, helping healthcare professionals diagnose and monitor diabetes with confidence. Through its integration with FlexLab™ X, laboratories can benefit from hands-free, standardized sample management, complete sample traceability, and automatic workflow balancing across multiple Tosoh GR01 analyzers – all supporting faster turnaround times, reduced manual interventions, and reliable, high-quality results.
“With the GR01, Tosoh reaffirms its commitment to advancing laboratory medicine by providing innovative, practical solutions that enhance productivity and efficiency – all while delivering real clinical benefit,” said Najoi Bettache, product manager, Tosoh Bioscience – Diagnostics EMEA1.
“This connection is particularly significant because of the way it integrates Tosoh’s advanced HPLC technology into a standardized, fully automated workflow,” said Silvia Cottini, Product Manager TTP Connections at Inpeco. “The uniqueness of this interface lies in how it preserves the analytical excellence of the GR01 while eliminating manual steps, ensuring total sample traceability, and minimizing errors associated with manual operations. It’s another step in our mission to help laboratories increase efficiency and reliability while improving patient care.”
Connection benefits at a glance
- Complete sample traceability – seamless traceability of individual sample journey, from check-in to the results.
- Automatic workload balancing to optimize turnaround time – Automatic workflow balancing among multiple Tosoh GR01 analyzers reduces turnaround time (TAT).
- Reduced manual interventions – hands-free operation reduces errors ensuring consistent, reliable results while freeing up technician time.
* HLC-723GR01 is a registered trademark of Tosoh Corporation.
About Inpeco
Inpeco is the global leader in Total Laboratory Automation. The company’s game-changing solutions combine open connectivity with full sample traceability to support secure test results and increase productivity in clinical laboratories around the world. To date, more than 2800 Inpeco systems have been shipped to 78 countries. Inpeco also provides automation for anatomical pathology labs and is developing solutions for blood banks and life sciences applications. The Group is headquartered in Novazzano, Switzerland, and operates a development and manufacturing facility in Italy, as well as sales offices in Europe, China, and the United States.
For more information, please visit: www.inpeco.com
About Tosoh
TOSOH CORPORATION
Tosoh Corporation is the parent of the Tosoh Group, which comprises over 100 companies worldwide and a multiethnic workforce of over 14,000 employees. It generated net sales of ¥1,063.4 billion (US$7.0 billion at the average rate of ¥150 to the US dollar) in fiscal 2025, ended March 31, 2025.
TOSOH BIOSCIENCE
By bringing the best in quality products, services and technologies from Tosoh Corporation, Tosoh Bioscience is dedicated to pioneering systems used to assist in monitoring life-threatening diseases and certain cancers, helping to prevent epidemics, purify water, monitor our environment, and making living better for everyone, everywhere.
Tosoh Bioscience is divided in two business units; Separation & Purification and Clinical Diagnostics;
The Separation & Purification business unit offers 500+ specialty products in analytical HPLC columns, chromatographic resins, and GPC instruments to meet laboratory and pharmaceutical needs.
The Clinical Diagnostics clinical business unit offers superior automated immunoassay and glycohemoglobin analysers, laboratory solutions, assays and test-cup reagents as solutions to laboratories, clinics, hospitals and veterinarians’ needs.
1Tessenderlo-Ham, Belgium-based Tosoh Europe N.V., using, “Tosoh Bioscience – Diagnostics EMEA” (Europe, the Middle East, and Africa) for marketing purposes, is part of this business unit.
For more information, please visit: www.tosohbioscience.eu